Find the Perfect Plan for Your Investment Journey
Last Price
52 Week Range
$1.94 - $10.31
Next Earnings Date
May 08 2025
Next Earnings Date
May 08 2025
Last Price
Market Cap | $4.55M |
EV | $465.24K |
Shares Outstanding | 1.37M |
Beta | 0.78 |
Analyst Rating | BUY |
Analyst Target Price | $12.00 |
P/E 2025E | - |
P/Revenue 2025E | 0.70x |
Revenue | -9.40% |
EPS | 42.80% |
Operating Cash Flow | 28.10% |
Free Cash Flow | 53.10% |
Revenue | - |
EPS | - |
Operating Cash Flow | - |
Free Cash Flow | - |
Gross Margin 2025E | 33.00% |
Net Profit Margin 2025E | -62.39% |
ROE 2025E | - |
ROCE 2024 | -45.29% |
DPS 2025E | - |
Payout Ratio 2025E | - |
Div. Yield 2025E | - |
DPS Last 3Y CAGR | - |
Price
%
1M
3M
6M
1Y
3Y
5Y
Arcadia Biosciences, Inc.
RKDA
Sector
Basic Materials
Industry
Agricultural Inputs
CEO
Schaefer, Thomas
Employees
9
Website
www.arcadiabio.comIPO Date
2015-05-15
Headquarters
5950 Sherry Lane, Suite 215, Dallas, Texas, 75225, United States
COMPANY
NEWSLETTER
© Copyright 2025, All Rights Reserved